By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
European CHMP Adopts Positive Opinion For Gilead (GILD)’s Epclusa(Sofosbuvir/Velpatasvir) For The Treatment Of All Genotypes Of Chronic Hepatitis C 5/27/2016 10:54:08 AM
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections 5/27/2016 6:13:35 AM
Count Celgene (CELG) and Gilead (GILD) as New Suitors to Acquire the Popular Medivation (MDVN) 5/25/2016 8:34:17 AM
Retired Gilead (GILD) Exec Returns as His Replacement Exits 5/25/2016 6:06:19 AM
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/24/2016 6:33:42 AM
Gilead (GILD) To Present At The UBS Global Healthcare Conference On Monday, May 23 5/23/2016 9:29:27 AM
Nimbus Therapeutics Announces Closing Of Gilead (GILD)’ Acquisition Of Nimbus Apollo, Inc., And Its Acetyl-CoA Carboxylase (ACC) Inhibitor Program 5/17/2016 11:09:22 AM
Gilead (GILD) Elated as India Upholds Sovaldi Patent 5/11/2016 6:52:16 AM
Gilead (GILD) To Present At The Bank of America (BAC) Merrill Lynch Healthcare Conference On Tuesday, May 10 5/10/2016 12:14:10 PM
Gilead (GILD) CEO Targets Cancer Acquisitions with $21 Billion Cash Pile 5/9/2016 6:24:40 AM